A New Hope for Follicular Lymphoma Patients in Japan
Follicular lymphoma (FL) is a significant health issue in Japan, the United States, and Western Europe. It stands as the second most frequent type of non-Hodgkin lymphoma (NHL). Parsaclisib is a drug that targets a specific pathway in cancer cells. It has shown promise in earlier tests with patients